Recently, the 2018 (35th) Annual National Pharmaceutical Industry Information Conference held by China Pharmaceutical Industry Information Center took place in Shanghai. The conference released a list of the top 100 pharmaceutical enterprises in China in 2017, which has attracted much attention from the industry.

Yangtze River Pharmaceutical Group, Guangzhou Pharmaceutical Holdings Limited, and Xiuzheng Pharmaceutical Group were among the top three.

19 companies among the list including Yangtze River Pharmaceutical Group, Shanghai Pharmaceutical Group Co., Ltd. Huirui Pharmaceuticals Limited, and Shandong Qilu Pharmaceutical Co., Ltd. all have set up R&D and operation centers in Zhangjiang High-tech Park.

According to the statistics and analysis of China Pharmaceutical Industry Information Center, the companies among the list continued their strong growth momentum. With the growth rate of 10.2% of main business revenue, the revenue of these companies exceeded RMB 750 billion. Although the growth rate was 0.9 percentage points lower than that of the same period last year, the growth trend remained basically stable. Notably, the entry threshold for the top 100 enterprises also rose 5% to RMB 2.56 billion from RMB 2.44 billion last year. Under the leading role of the top 100 enterprises, the pharmaceutical industry is gradually moving towards economies of scale. (Source: Zhangjiang Online)